078160 — Medipost Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Medipost Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-1,896	-966	2,106	4,951	-63,378
Depreciation
Amortisation
Non-Cash Items	4,577	2,912	-10,547	-25,770	20,892
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-5,999	-2,787	-3,133	-4,130	-802
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,785	4,056	-6,192	-19,078	-37,266
Capital Expenditures	-8,065	-10,704	-3,556	-2,614	-3,260
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	4,826	2,511	-104,324	-25,478	34,642
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-3,238	-8,194	-107,880	-28,092	31,382
Financing Cash Flow Items	-778	147	189	-21.3	572
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,113	5,661	118,536	70,157	-1,081
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2,634	1,501	4,068	22,667	-4,856